Mondelez International (MDLZ)
NASDAQConsumer StaplesFood ConfectionersSnapshot 2026-09-04
NASDAQConsumer StaplesFood ConfectionersSnapshot 2026-09-04
Research Workspace
Put MDLZ beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Packaged Foods & Meats: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Organic Net Revenue growth of flat to 2% for 2026: FY26 organic revenue guidance +2.0% vs target 0%-2% (at lower bound).
View ThesisRevenue is growing steadily — about 7% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery.
View ManagementExpectations look high — the market is pricing in about 22% growth a year, above the roughly 3% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMDLZ's growth relies on achieving organic net revenue growth of flat to 2%. Recent earnings results show steady demand, with revenue growing 4.1% year over year and a recent earnings beat. The stock trades at 21.5× P/E versus a peer median of 12.5×, indicating the market prices in more growth than currently forecast. The primary risk is the potential for a guidance cut, with a 13% probability of a miss in the next quarter. Peer multiples imply a price about 22% below where it trades (it looks expensive on this basis). This read is provisional.
Trailing returns as of 2026-09-04. MDLZ is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering MDLZ (as of Sep 2026).
Based on 5 Wall Street analysts offering 12-month price targets for MDLZ in the last 4 months.
Continue this research
Compare MDLZ with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MDLZ Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Packaged Foods & Meats — fair value, gap to price, and forward P/E.
Compare the value case
Put MDLZ next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
CEO selling shares raises concerns about confidence.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $61.28
The last 12 months of price, then the range of analyst 12-month targets from today’s $61.28.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Factory attack may disrupt operations and impact revenue.

Upgraded outlook suggests stronger revenue growth potential.

Threatens: Organic Net Revenue growth of flat to 2%
Price cuts not boosting volumes threatens revenue growth objective.

Threatens: Organic Net Revenue growth of flat to 2%
Earnings beat may not support long-term growth expectations.
Advances: Organic Net Revenue growth of flat to 2%
Strong demand supports organic revenue growth objective.

Advances: Organic Net Revenue growth of flat to 2%
Strong demand supports organic revenue growth objective.
Advances: Organic Net Revenue growth of flat to 2%
Strong demand supports organic revenue growth objective.